Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?

N Engl J Med. 2004 Feb 26;350(9):934-6. doi: 10.1056/NEJMe048001.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Drug Resistance
  • Drug Tolerance
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / immunology
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Intestinal Fistula / drug therapy*
  • Intestinal Fistula / etiology
  • Recurrence
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab